This restriction applies regardless of body weight, metabolic status, or how well other treatments might work
Your PlexusDx provider supplies a medical prescription and documentation confirming that GLP-1 therapy addresses a qualifying condition
If your plan provides oral semaglutide insurance coverage, your out-of-pocket expenses might be minimal, limited to your copay or coinsurance
Appetite signaling may gradually return toward its pre-treatment state, gastric emptying often normalizes, and reductions in lean body (muscle) mass associated with GLP-1 use may lead to a lower resting metabolic rate following discontinuation, meaning fewer calories are burned at rest
Yes, but effectiveness may decrease because semaglutide slows stomach emptying and reduces oral medication absorption
If standard doses are not tolerated, clinically appropriate alternatives might include slower titration (still within SmPC guidelines), switching to a different GLP-1 receptor agonist, considering other medication classes, enhancing diet/lifestyle support, or specialist review